Carol Paronis - Publications

McLean Hospital, Harvard Medical School, Belmont, MA, United States 

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wang M, Irvin TC, Herdman CA, Hanna RD, Hassan SA, Lee YS, Kaska S, Crowley RS, Prisinzano TE, Withey SL, Paronis CA, Bergman J, Inan S, Geller EB, Adler MW, et al. The Intriguing Effects of Substituents in the -Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules (Basel, Switzerland). 25. PMID 32517185 DOI: 10.3390/molecules25112640  0.96
2019 Withey SL, Spealman RD, Bergman J, Paronis CA. Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment. The Journal of Pharmacology and Experimental Therapeutics. PMID 31413139 DOI: 10.1124/jpet.119.259010  0.96
2018 Chopda GR, Nikas SP, Sharma R, Kulkarni S, Makriyannis A, Paronis CA. Cannabinoid-induced lower lip retraction in rats. Psychopharmacology. PMID 30460515 DOI: 10.1007/s00213-018-5125-z  0.4
2018 Withey SL, Paronis CA, Bergman J. Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys. The Journal of Pain : Official Journal of the American Pain Society. PMID 29477761 DOI: 10.1016/j.jpain.2018.02.003  0.96
2018 Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J. Long-lasting in vivo effects of the cannabinoid CB1 antagonist AM6538. The Journal of Pharmacology and Experimental Therapeutics. PMID 29311110 DOI: 10.1124/jpet.117.245647  0.96
2016 Kulkarni S, Nikas SP, Sharma R, Jiang S, Paronis CA, Leonard MZ, Zhang B, Honrao C, Mallipeddi S, Raghav JG, Benchama O, Järbe TU, Bergman J, Makriyannis A. Novel C-Ring-Hydroxy-substituted Controlled Deactivation Cannabinergic Analogues. Journal of Medicinal Chemistry. PMID 27367336 DOI: 10.1021/acs.jmedchem.6b00717  0.96
2016 Chopda GR, Parge VA, Thakur G, Gatley SJ, Makriyannis A, Paronis CA. Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27231154 DOI: 10.1124/jpet.116.232132  0.96
2015 Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, et al. Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols. Journal of Medicinal Chemistry. 58: 665-81. PMID 25470070 DOI: 10.1021/jm501165d  0.96
2013 Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A. Controlled-deactivation cannabinergic ligands. Journal of Medicinal Chemistry. 56: 10142-57. PMID 24286207 DOI: 10.1021/jm4016075  0.96
2013 Chopda GR, Vemuri VK, Sharma R, Thakur GA, Makriyannis A, Paronis CA. Diuretic effects of cannabinoid agonists in mice. European Journal of Pharmacology. 721: 64-9. PMID 24099963 DOI: 10.1016/j.ejphar.2013.09.053  0.96
2013 Thakur GA, Bajaj S, Paronis C, Peng Y, Bowman AL, Barak LS, Caron MG, Parrish D, Deschamps JR, Makriyannis A. Novel adamantyl cannabinoids as CB1 receptor probes. Journal of Medicinal Chemistry. 56: 3904-21. PMID 23621789 DOI: 10.1021/jm4000775  0.96
2013 Paronis CA, Thakur GA, Bajaj S, Nikas SP, Vemuri VK, Makriyannis A, Bergman J. Diuretic effects of cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 344: 8-14. PMID 23019138 DOI: 10.1124/jpet.112.199331  0.96
2012 Paronis CA, Nikas SP, Shukla VG, Makriyannis A. Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Behavioural Pharmacology. 23: 802-5. PMID 23075707 DOI: 10.1097/FBP.0b013e32835a7c4d  0.96
2011 Paronis CA, Bergman J. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 336: 488-95. PMID 21051498 DOI: 10.1124/jpet.110.173823  0.96
2010 Nikas SP, Alapafuja SO, Papanastasiou I, Paronis CA, Shukla VG, Papahatjis DP, Bowman AL, Halikhedkar A, Han X, Makriyannis A. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist. Journal of Medicinal Chemistry. 53: 6996-7010. PMID 20925434 DOI: 10.1021/jm100641g  0.96
2010 Desai RI, Paronis CA, Martin J, Desai R, Bergman J. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. The Journal of Pharmacology and Experimental Therapeutics. 333: 834-43. PMID 20190012 DOI: 10.1124/jpet.110.165746  0.96
2008 Bergman J, Delatte MS, Paronis CA, Vemuri K, Thakur GA, Makriyannis A. Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiology & Behavior. 93: 666-70. PMID 18076956 DOI: 10.1016/j.physbeh.2007.11.007  0.96
2008 Delatte MS, Paronis CA. Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys. Psychopharmacology. 198: 521-8. PMID 17882403 DOI: 10.1007/s00213-007-0918-5  0.4
2007 Desai RI, Neumeyer JL, Bergman J, Paronis CA. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behavioural Pharmacology. 18: 745-54. PMID 17989512 DOI: 10.1097/FBP.0b013e3282f14ee6  0.96
2007 Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. European Journal of Pharmacology. 558: 98-106. PMID 17207791 DOI: 10.1016/j.ejphar.2006.11.042  0.96
2006 Bergman J, Paronis CA. Measuring the reinforcing strength of abused drugs. Molecular Interventions. 6: 273-83. PMID 17035668 DOI: 10.1124/mi.6.5.9  0.96
2005 Gasior M, Bergman J, Kallman MJ, Paronis CA. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 758-64. PMID 15526000 DOI: 10.1038/sj.npp.1300593  0.96
2004 Gasior M, Paronis CA, Bergman J. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 308: 249-59. PMID 14563783 DOI: 10.1124/jpet.103.052795  0.96
2003 Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychological Bulletin. 129: 270-304. PMID 12696841 DOI: 10.1037/0033-2909.129.2.270  0.96
2003 Yasar S, Bergman J, Munzar P, Redhi G, Tober C, Knebel N, Zschiesche M, Paronis C. Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys. European Journal of Pharmacology. 465: 257-65. PMID 12681437 DOI: 10.1016/S0014-2999(03)01533-4  0.96
2002 Paronis CA, Gasior M, Bergman J. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys. Psychopharmacology. 163: 283-91. PMID 12373429 DOI: 10.1007/s00213-002-1180-5  0.96
Show low-probability matches.